Mediserv Pharma SRL
Mediserv Pharma reported revenue of 168,234 € for the 2025 financial year (annual accounts filed with the NBB on 02 Oct 2026).
The score of Mediserv Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mediserv Pharma's annual accounts
| 2025 | |
|---|---|
| Revenue | 168,234 € |
| Net result | 53,628 € |
| Equity | 56,628 € |
| Cash | 36,137 € |
| EBITDA | 74,136 € |
| Total assets | 126,318 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Oct 2026
Mediserv Pharma's financial analysis
- Solvency44.8%sector median: 47.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mediserv Pharma
Mediserv Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1016.940.773
- VAT number
- BE1016940773
- Peppol
- Registered · 0208:1016940773 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Dec 2024
- Registered office
- 2830 Willebroek
- Latest accounts
- 2025 · filed on 02 Oct 2026
- Activity
- Retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses (NACE 47741)
Mediserv Pharma (SRL) has been based in Willebroek since 2024, active in: retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses. For 2025, it reports revenue of 168,234 €, a net profit of 53,628 € and equity of 56,628 €. Its solvency stands at 44.8%, below the median of its sector (47.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Mediserv Pharma
Companies in the same business, of comparable size and area, outside its group.
- Hooratelier Retail sale of medical and orthopaedic goods Duffel · balance sheet 455,490 €
- INOUI Audition Retail sale of medical and orthopaedic goods Evere · balance sheet 108,235 €
- SRL Whisper Audition Retail sale of medical and orthopaedic goods Brussels · balance sheet 111,317 €
- Soyin Retail sale of medical and orthopaedic goods Deinze · balance sheet 139,162 €
- NS Drone Projects Retail sale of medical and orthopaedic goods Lendelede · balance sheet 766 €
- Centre Auditif Brane Retail sale of medical and orthopaedic goods Libin · balance sheet 149,090 €
- Audilis Retail sale of medical and orthopaedic goods Chaudfontaine · balance sheet 119,529 €
- Eyeland Optics Retail sale of medical and orthopaedic goods Antwerp · balance sheet 150,587 €
Frequently asked questions about Mediserv Pharma
What is the revenue of Mediserv Pharma?
According to the 2025 annual accounts filed with the NBB, the revenue of Mediserv Pharma amounts to 168,234 €.
What is the VAT number of Mediserv Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1016940773 for Mediserv Pharma, if the company is VAT-registered. Its company number (CBE) is 1016.940.773.
Where is the registered office of Mediserv Pharma?
According to the CBE register, the registered office of Mediserv Pharma is in 2830 Willebroek.
What is the equity of Mediserv Pharma?
At the close of the 2025 financial year, the equity of Mediserv Pharma amounts to 56,628 €, a solvency of 44.8% of total assets.
Who manages Mediserv Pharma?
The register lists 1 active mandates at Mediserv Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mediserv Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →